Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantifying the indirect treatment effect via surrogate markers.

Yongming Qu1, Michael Case

  • 1Eli Lilly and Company, Indianapolis, IN 46285, USA. qu_yongming@lilly.com

Statistics in Medicine
|September 7, 2005
PubMed
Summary

This study introduces a new method to quantify causal relationships between multiple surrogate markers, advancing the understanding of treatment effect proportion. It generalizes path analysis for better treatment effect decomposition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting the Treatment Regimen Estimand in Phase 3 Studies from the Estimated Efficacy Estimand Based on Phase 2 Data.

Therapeutic innovation & regulatory science·2026
Same author

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Diabetes care·2026
Same author

Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial Program.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026
Same author

Relationships Between Metabolic and Bariatric Surgery and Adverse Kidney Outcomes: An Analysis of a Retrospective Cohort.

Obesity science & practice·2025
Same author

Bayesian Integrated Learning of Longitudinal Dose-Response Relationships via Decentralized Clinical Trials.

Statistics in medicine·2025
Same author

Estimand Endpoints for Longitudinal Measures of Continuous Disease Progression with an Alzheimer's Disease Example.

Therapeutic innovation & regulatory science·2025

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Trial Methodology

Background:

  • Existing research quantifies treatment effect proportion (PTE) via surrogate markers, often focusing on single markers or ignoring inter-marker causal relationships.
  • The influence of one surrogate marker on another necessitates methods that account for these complex associations.

Purpose of the Study:

  • To propose a novel method for quantifying the causal relationship between multiple surrogate markers.
  • To extend the analysis of PTE to include inter-marker causal pathways.

Main Methods:

  • Developed a method to quantify the causal relationship between surrogate markers.
  • Extended path analysis principles to generalized linear models and Cox regression models.
  • Applied to analyze the proportion of treatment effect explained by multiple, causally linked surrogate markers.

Related Experiment Videos

Main Results:

  • The proposed method quantifies the causal interplay between surrogate markers.
  • This approach provides a more comprehensive understanding of PTE decomposition when markers are interrelated.
  • The method generalizes existing path analysis techniques.

Conclusions:

  • The new method offers a robust framework for analyzing complex surrogate marker relationships in clinical trials.
  • It enhances the ability to accurately assess the proportion of treatment effect mediated by multiple, causally linked surrogate markers.
  • This work advances statistical methodologies for evaluating treatment efficacy through surrogate endpoints.